乳がん診断の市場規模、シェア、動向分析レポート：製品別、タイプ別、用途別、最終用途別、地域別、セグメント別予測、2023年～2030年

乳がん診断市場の成長と動向：

Grand View Research, Inc.の新しい調査によると、世界の乳がん診断市場規模は2030年までに77億米ドルに達する見込みです。

同市場は2023年から2030年にかけてCAGR 7.4％で拡大する見込みです。この成長は、乳がんに対する意識の高まりと相まって、乳がんのリスクと早期発見にさらされる老年人口の増加に大きく起因しています。

2Dマンモグラフィよりも精度の高い3Dマンモグラフィやデジタル乳房トモシンセシスのイントロダクションが市場の成長を支えています。この先進技術は、2Dマンモグラフィよりも40.0%多くがんを検出でき、患者のリコールを減らすことができます。急速な技術の進歩は、今後数年間市場を牽引すると予想される主な要因です。

企業は、自社のリソースを新製品の開発に役立てるとともに、サプライチェーンを強化する戦略を採用しています。2019年11月には、Exact Sciences CorporationがGenomic Healthの買収を発表し、同社の製品ポートフォリオを獲得することで、市場での地位と提供サービスの強化に貢献すると期待されました。2021年1月、Hologic Inc.はBiotheranostics社を約2億3,000万米ドルで買収することで合意したと発表しました。Biotheranostics社は、乳がんや転移性がんを対象とした商業段階の分子診断薬プロバイダーです。

乳がんの予測検査やコンパニオン診断検査の発売が増加していることから、市場の成長が期待されています。このセグメントにおける最近の発売には、乳がんコンパニオン診断薬として2018年にFDAの承認を取得したMyriad Genetics社のBRACAnalysis CDxが含まれます。2019年5月、QIAGEN社は、組織生検やリキッド生検からの治療決定の指針となるNovartis社独自のPIQRAYのコンパニオン診断薬としてtherascreen PIK3CA RGQ PCR Kitを発表しました。

2019年1月、富士フイルムホールディングス株式会社は、ASPIRE Cristalleマンモグラフィシステム用のトモシンセシス生検オプションを発表しました。この技術は、強化された3D画像とデジタルマンモグラムを提供することで、医師が他と比較してより効率的に乳がんを検出できるようになると期待されました。

しかし、これらの画像診断には特有の危険因子があります。それらは、大量の蛍光造影剤やバリウム造影剤を投与すること、画像診断や内視鏡検査の場合には放射線被曝を伴うことであり、吐き気や下痢などいくつかの副作用を引き起こす可能性があります。CT、MRI、X線の使用に伴う電離放射線被曝のリスクや、PETにおける放射性トレーサー注射の使用は、このようなスクリーニング法の採用を制限する可能性があります。したがって、画像診断の副作用などの要因は、この市場の企業にとって課題となっています。

乳がん診断市場レポートハイライト

• 2022年の収益シェアは画像診断分野が最も大きく、血液検査分野が最も速い速度で成長すると予測されます。
• 製品別では、米国、カナダ、英国などの先進諸国における45歳以上の女性に対する検診義務化などの政府の取り組みにより、乳がんの検査・検診全体が増加しているため、機器ベースの製品セグメントが2022年に最大の収益シェアを占めました。
• プラットフォームベースの製品セグメントは、予測期間中に最も速い成長を示すと予想されます。これらの検査は、主に女性における化学療法や標的療法の有効性を評価するために使用されます。
• 用途別では、診断・予測セグメントが2022年の市場を独占し、診断の進歩に向けた共同研究や取り組みの増加により、予後予測セグメントが予測期間中に最も速いCAGRを示すと予想されます。
• 2022年の市場は、病院・診療所セグメントが支配的でした。
• 医療ラボと診断センターセグメントは、NGSやPCRのようなプラットフォームベースの検査の増加により、予測期間で最も速いCAGRが見込まれます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 乳がん診断市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 普及と成長の見通しマッピング
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因分析
• 乳がん診断市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 乳がん診断：タイプの推定・動向分析

• 乳がん診断市場、重要なポイント
• 乳がん診断市場：動向と市場シェア分析、2022年および2030年
• イメージング
  • イメージング市場推計・予測、2018年から2030年まで
• 生検
  • 生検市場推計・予測、2018年から2030年まで
• ゲノム検査
  • ゲノム検査市場推計・予測、2018年から2030年まで
• 血液検査
  • 血液検査市場推計・予測、2018年から2030年まで
• その他
  • その他の市場推計・予測、2018年から2030年まで

第5章 乳がん診断：製品の推定・動向分析

• 乳がん診断市場、重要なポイント
• 乳がん診断市場：動向と市場シェア分析、2022年と2030年
• プラットフォームベースの製品
• 計測器ベースの製品

第6章 乳がん診断：用途の推定・動向分析

• 乳がん診断市場、重要なポイント
• 乳がん診断市場：動向と市場シェア分析、2022年および2030年
• スクリーニング
  • スクリーニング市場推計・予測、2018年から2030年まで
• 診断と予測
  • 診断および予測市場推計・予測、2018年から2030年まで
• 予後
  • 予後市場推計・予測、2018年から2030年まで
• 調査
  • 2018年から2030年までの市場推計・予測を調査

第7章 乳がん診断：最終使用推定・動向分析

• 乳がん診断市場、重要なポイント
• 乳がん診断市場：動向と市場シェア分析、2022年と2030年
• 病院とクリニック
• 診断センターと医療研究所
• その他

第8章 乳がん診断市場：地域別の推定・動向分析

• 地域別の展望
• 地域別の乳がん診断市場：重要なポイント
• 北米
  • 市場推計・予測、2018～2030年
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • スウェーデン
  • ノルウェー
  • デンマーク
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 会社/競合の分類
  • Hologic Inc.
  • Genomic Health (Exact Sciences Corporation)
  • BD
  • Danaher
  • Koninklijke Philips N.V.
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Myriad Genetics, Inc.
  • Argon Medical Devices, Inc.
  • F. Hoffmann-La Roche Ltd.

List of Tables

• Table 1 List of abbreviation
• Table 2 North America breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 3 North America breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 4 North America breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 5 North America breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 6 North America breast cancer diagnostics market, by region, 2018 - 2030 (USD Million)
• Table 7 U.S. breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 8 U.S. breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 9 U.S. breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 10 U.S. breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 11 Canada breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 12 Canada breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 13 Canada breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 14 Canada breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 15 Europe breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 16 Europe breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 17 Europe breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 18 Europe breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 19 Europe breast cancer diagnostics market, by region, 2018 - 2030 (USD Million)
• Table 20 Germany breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 21 Germany breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 22 Germany breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 23 Germany breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 24 UK breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 25 UK breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 26 UK breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 27 UK breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 28 France breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 29 France breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 30 France breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 31 France breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 32 Italy breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 33 Italy breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 34 Italy breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 35 Italy breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 36 Spain breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 37 Spain breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 38 Spain breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 39 Spain breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 40 Sweden breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 41 Sweden breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 42 Sweden breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 43 Sweden breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 44 Norway breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 45 Norway breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 46 Norway breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 47 Norway breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 48 Denmark breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 49 Denmark breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 50 Denmark breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 51 Denmark breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 52 Asia Pacific breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 53 Asia Pacific breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 54 Asia Pacific breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 55 Asia Pacific breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 56 Asia Pacific breast cancer diagnostics market, by region, 2018 - 2030 (USD Million)
• Table 57 Japan breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 58 Japan breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 59 Japan breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 60 Japan breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 61 China breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 62 China breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 63 China breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 64 China breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 65 India breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 66 India breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 67 India breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 68 India breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 69 Australia breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 70 Australia breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 71 Australia breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 72 Australia breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 73 Thailand breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 74 Thailand breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 75 Thailand breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 76 Thailand breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 77 South Korea breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 78 South Korea breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 79 South Korea breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 80 South Korea breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 81 Latin America breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 82 Latin America breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 83 Latin America breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 84 Latin America breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 85 Latin America breast cancer diagnostics market, by region, 2018 - 2030 (USD Million)
• Table 86 Brazil breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 87 Brazil breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 88 Brazil breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 89 Brazil breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 90 Mexico breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 91 Mexico breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 92 Mexico breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 93 Mexico breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 94 Argentina breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 95 Argentina breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 96 Argentina breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 97 Argentina breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 98 Middle East and Africa breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 99 Middle East and Africa breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 100 Middle East and Africa breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 101 Middle East and Africa breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 102 Middle East and Africa breast cancer diagnostics market, by region, 2018 - 2030 (USD Million)
• Table 103 Saudi Arabia breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 104 Saudi Arabia breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 105 Saudi Arabia breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 106 Saudi Arabia breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 107 South Africa breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 108 South Africa breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 109 South Africa breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 110 South Africa breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 111 UAE breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 112 UAE breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 113 UAE breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 114 UAE breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
• Table 115 Kuwait breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
• Table 116 Kuwait breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 117 Kuwait breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 118 Kuwait breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Breast cancer diagnostics: Market outlook
• Fig. 9 Breast cancer diagnostics: Competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Industry value chain analysis
• Fig. 14 Breast cancer diagnostics market driver impact
• Fig. 15 Breast cancer diagnostics market restraint impact
• Fig. 16 Breast cancer diagnostics strategic initiatives analysis
• Fig. 17 Breast cancer diagnostics market: Type movement analysis
• Fig. 18 Breast cancer diagnostics market: Type outlook and key takeaways
• Fig. 19 Imaging market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Genomic tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Blood tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Breast cancer diagnostics market: Product movement analysis
• Fig. 25 Breast cancer diagnostics market: Product outlook and key takeaways
• Fig. 26 Platform based products market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Next-generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Instruments-based products market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Imaging market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Breast cancer diagnostics market: Application movement analysis
• Fig. 34 Breast cancer diagnostics market: Application outlook and key takeaways
• Fig. 35 Screening market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Diagnostic and predictive market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Prognostic market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Research market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Breast cancer diagnostics market: End-use movement analysis
• Fig. 40 Breast cancer diagnostics market: End-use outlook and key takeaways
• Fig. 41 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Diagnostic centers and medical laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Global breast cancer diagnostics market: Regional movement analysis
• Fig. 45 Global breast cancer diagnostics market: Regional outlook and key takeaways
• Fig. 46 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Breast Cancer Diagnostics Market Growth & Trends:

The global breast cancer diagnostics market size is expected to reach USD 7.7 billion by 2030, according to a new study by Grand View Research, Inc.. The market is expected to expand at a CAGR of 7.4% from 2023 to 2030. The growth is largely attributable to the increasing geriatric population exposed to the risk of breast cancer and early detection coupled with increasing awareness about breast cancer.

The introduction of 3D mammography or digital breast tomosynthesis, which is more accurate than 2D mammography, supports market growth. This advanced technology can detect 40.0% more cancers than 2D mammograms and reduce patient recalls. Rapid technological advancements are a major factor expected to drive the market over the coming years.

Companies are adopting strategies that allow them to use their resources to aid in the development of new products, as well as enhance their supply chain. In November 2019, Exact Sciences Corporation announced the acquisition of Genomic Health, which was expected to help enhance the company's market position and offerings by acquiring its product portfolio. In January 2021, Hologic Inc. announced that it has agreed to acquire Biotheranostics for approximately US$ 230 million. Biotheranostics is a commercial-stage molecular diagnostics provider for breast and metastatic cancers.

The increasing launch of predictive and companion diagnostic tests for breast cancer is expected to boost the market growth. Recent launches in the segment include BRACAnalysis CDx by Myriad Genetics, which received FDA approval in 2018 as breast cancer companion diagnostics. In May 2019, QIAGEN introduced therascreen PIK3CA RGQ PCR Kit as a companion diagnostic for Novartis proprietary PIQRAY in guiding treatment decisions from tissue and liquid biopsy.

In January 2019, the Fujifilm Holdings Corporation introduced its Tomosynthesis Biopsy option for ASPIRE Cristalle mammography system. This technique was expected to enable physicians to detect breast cancers more efficiently compared to others by providing an enhanced 3D image and a digital mammogram.

However, there are specific risk factors associated with these imaging procedures. They involve administering high doses of fluorescent and barium contrast agents, as well as radiation exposure in the case of imaging and endoscopic procedures, which can cause several adverse effects such as nausea or diarrhea. The risks of ionizing radiation exposure associated with the use of CT, MRI, and X-rays, as well as the use of radioactive tracer injections in PET can limit the adoption of such screening procedures. Therefore, factors such as adverse effects of imaging act as a challenge for the companies in this market.

Breast Cancer Diagnostics Market Report Highlights:

• The imaging segment held the largest revenue share in 2022 and the blood tests segment is expected to grow at the fastest rate
• By product, the instrument-based products segment accounted for the largest revenue share in 2022 due to government initiatives such as mandatory screening in developed countries such as the U.S., Canada, and the U.K. for women above 45 years of age, increasing the overall testing and screening of breast cancer
• The platform-based products segment is expected to witness the fastest growth over the forecast period. These tests are mostly used for assessing the efficacy of chemotherapy and targeted therapy in women
• By application, the diagnostic and predictive segment dominated the market in 2022 and the prognostic segment is expected to witness the fastest CAGR over the forecast period due to increasing collaborations and efforts for advancements in diagnostics
• The hospitals and clinics segment dominated the market in 2022
• The medical labs and diagnostics centers segment is expected to witness the fastest CAGR over the forecast period due to an increase in platform-based testing such as NGS, and PCR

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Type
  • 1.1.2. Product
  • 1.1.3. Application
  • 1.1.4. End-use
  • 1.1.5. Regional scope
  • 1.1.6. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Product outlook
  • 2.2.3. Application outlook
  • 2.2.4. End-use outlook
  • 2.2.5. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Breast Cancer Diagnostics Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
  • 3.3.2. Market restraint analysis
• 3.4. Breast Cancer Diagnostics Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. Breast Cancer Diagnostics: Type Estimates & Trend Analysis

• 4.1. Breast Cancer Diagnostics Market, Key Takeaways
• 4.2. Breast Cancer Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
• 4.3. Imaging
  • 4.3.1. Imaging market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.4. Biopsy
  • 4.4.1. Biopsy market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Genomic Tests
  • 4.5.1. Genomic tests market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.6. Blood Tests
  • 4.6.1. Blood tests market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Breast Cancer Diagnostics: Product Estimates & Trend Analysis

• 5.1. Breast Cancer Diagnostics Market, Key Takeaways
• 5.2. Breast Cancer Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
• 5.3. Platform-based Products
  • 5.3.1. Platform-based products market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.1.1. Next-generation sequencing
    • 5.3.1.1.1. Next-generation sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.1.2. Microarrays
    • 5.3.1.2.1. Microarrays market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.1.3. PCR
    • 5.3.1.3.1. PCR market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.1.4. Others
    • 5.3.1.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.4. Instruments-based Products
  • 5.4.1. Instruments-based products market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.1.1. Imaging
    • 5.4.1.1.1. Imaging market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.4.1.2. Biopsy
    • 5.4.1.2.1. Biopsy market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Breast Cancer Diagnostics: Application Estimates & Trend Analysis

• 6.1. Breast Cancer Diagnostics Market, Key Takeaways
• 6.2. Breast Cancer Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
• 6.3. Screening
  • 6.3.1. Screening market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.4. Diagnostic and Predictive
  • 6.4.1. Diagnostic and predictive market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Prognostic
  • 6.5.1. Prognostic market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.6. Research
  • 6.6.1. Research market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Breast Cancer Diagnostics: End-use Estimates & Trend Analysis

• 7.1. Breast Cancer Diagnostics Market, Key Takeaways
• 7.2. Breast Cancer Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
• 7.3. Hospitals & Clinics
  • 7.3.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.4. Diagnostic Centers and Medical Laboratories
  • 7.4.1. Diagnostic centers and medical laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.5. Others
  • 7.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Breast Cancer Diagnostics Market: Regional Estimates & Trend Analysis

• 8.1. Regional Outlook
• 8.2. Breast Cancer Diagnostics Market by Region: Key Takeaway
• 8.3. North America
  • 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4.3. France
    • 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4.6. Sweden
    • 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4.7. Norway
    • 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5.2. China
    • 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5.3. India
    • 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5.5. Thailand
    • 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5.6. South Korea
    • 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6.2. Mexico
    • 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 8.7. MEA
  • 8.7.1. Saudi Arabia
    • 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/Competition Categorization
  • 9.2.1. Hologic Inc.
    • 9.2.1.1. Company overview
    • 9.2.1.2. Financial performance
    • 9.2.1.3. Product Benchmarking
    • 9.2.1.4. Strategic initiatives
  • 9.2.2. Genomic Health (Exact Sciences Corporation)
    • 9.2.2.1. Company overview
    • 9.2.2.2. Financial performance
    • 9.2.2.3. Product benchmarking
    • 9.2.2.4. Strategic initiatives
  • 9.2.3. BD
    • 9.2.3.1. Company overview
    • 9.2.3.2. Financial performance
    • 9.2.3.3. Product benchmarking
    • 9.2.3.4. Strategic initiatives
  • 9.2.4. Danaher
    • 9.2.4.1. Company overview
    • 9.2.4.2. Financial performance
    • 9.2.4.3. Product benchmarking
    • 9.2.4.4. Strategic initiatives
  • 9.2.5. Koninklijke Philips N.V.
    • 9.2.5.1. Company overview
    • 9.2.5.2. Financial performance
    • 9.2.5.3. Product benchmarking
    • 9.2.5.4. Strategic initiatives
  • 9.2.6. QIAGEN
    • 9.2.6.1. Company overview
    • 9.2.6.2. Financial performance
    • 9.2.6.3. Product benchmarking
    • 9.2.6.4. Strategic initiatives
  • 9.2.7. Thermo Fisher Scientific Inc.
    • 9.2.7.1. Company overview
    • 9.2.7.2. Financial performance
    • 9.2.7.3. Product benchmarking
    • 9.2.7.4. Strategic initiatives
  • 9.2.8. Myriad Genetics, Inc.
    • 9.2.8.1. Company overview
    • 9.2.8.2. Financial performance
    • 9.2.8.3. Product benchmarking
    • 9.2.8.4. Strategic initiatives
  • 9.2.9. Argon Medical Devices, Inc.
    • 9.2.9.1. Company overview
    • 9.2.9.2. Financial performance
    • 9.2.9.3. Product benchmarking
    • 9.2.9.4. Strategic initiatives
  • 9.2.10. F. Hoffmann-La Roche Ltd.
    • 9.2.10.1. Company overview
    • 9.2.10.2. Financial performance
    • 9.2.10.3. Product benchmarking
    • 9.2.10.4. Strategic initiatives